Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis

International Immunopharmacology

Volumn 2, Issue 5, 2002, Pages 653-672

  Davenport, Colleen M ^a   McAdams, Holly Ann ^a   Kou, Jen ^a   Mascioli, Kirsten ^a   Eichman, Christopher ^a   Healy, Laura ^a   Peterson, John ^a   Murphy, Sreekant ^b   Coppola, Domenico ^c   Truneh, Alemseged ^a  

^a GLAXOSMITHKLINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmune disease; Co stimulation; Inflammation; Inflammatory bowel disease; T cells

Indexed keywords

CYCLOSPORIN A; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOPSY; COLITIS; COLON; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOCYTE; HISTOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN; SKIN BLOOD FLOW; SKIN DEFECT; T LYMPHOCYTE; WEIGHT REDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; COLON; CYTOKINES; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MICE; MICE, SCID; PSORIASIS; SKIN;

EID: 18344391018     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00201-6     Document Type: Article

References (49)

1. + T cells
2. + T cells are important for the balance between protective and pathogenic cell-mediated immunity
3. Intestinal epithelial barrier function: Neutrophil transepithelial migration
4. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
5. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease
6. Effector and regulatory lymphoid cells and cytokines in mucosal sites
7. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease: Kinetics of in vitro response to interferon gamma inducers
8. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype
9. T cells in inflammatory bowel disease - Protective and pathogenic roles
10. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
11. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
12. + T cells
13. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder
14. CD28/CTLA-4 and CD80/CD86 families - Signaling and function
15. Immunosuppression through blockade of CD28-B7-mediated costimulatory signals
16. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
17. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
18. Treatment of murine lupus with CTLA4-Ig
19. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/GP39 costimulation pathways
20. CTLA4-Ig gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice
21. CTLA4-Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus
22. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2
23. Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis
24. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
25. Inhibition by CTLA4-Ig of experimental allergic encephalomyelitis
26. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis
27. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
28. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis
29. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
30. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis
31. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model
32. Topical CTLA4-Ig suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis
33. Suppressive effects of CTLA4-Ig on nasal allergic reactions in presensitized murine model
34. Differential effect of CTLA4-Ig on murine graft-versus-host disease (GVHD) development - CTLA4-Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD
35. In vivo blockade of CD28/CTLA4 - B7 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice
36. Transplantation of anergic histoincompatible bone marrow allografts
37. CTLA4-Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
38. Severe combined immunodeficiency mouse and human psoriatic skin chimeras - Validation of a new animal model
39. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and b70 (B7.2) - Analysis by site directed mutagenesis
40. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
41. Regulatory T cells and inflammatory bowel disease
42. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation
43. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells
44. CTLA4-Ig: A novel immunosuppressive agent
45. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
46. Specificity of effector T lymphocytes in autologous graft-versus-host disease - Role of the major histocompatibility complex class II invariant chain peptide
47. Cyclosporin A-induced autologous graft-versus-host disease: A prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants
48. Experimental models of inflammatory bowel disease